Portal de Periódicos da CAPES

Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc study

2022; Elsevier BV; Volume: 17; Linguagem: Inglês

10.1016/j.lanepe.2022.100371

2666-7762

Julian Stumpf, Jörg Schwöbel, Tom H. Lindner, Leona Anders, Torsten Siepmann, Claudia Karger, Jan Hüther, Heike Martin, Petra Müller, Robert Faulhaber‐Walter, Torsten Langer, Holger Schirutschke, Thomas Stehr, Frank Meistring, Annegret Pietzonka, Kirsten Anding‐Rost, Katja Escher, Frank Pistrosch, J.-C. Schewe, Harald Seidel, Kerstin Barnett, Thilo Pluntke, Simon Cerny, Alexander Paliege, Ingolf Bast, Anne Steglich, Florian Gembardt, Friederike Kessel, Hannah Kröger, Patrick Arndt, Jan Sradnick, Kerstin Frank, Anna Klimová, René Mauer, Xina Grählert, Torsten Tonn, Christian Hugo,

COVID-19 epidemiological studies

Vulnerable dialysis and kidney transplant patients show impaired seroconversion rates compared to medical personnel eight weeks after SARS-CoV-2mRNA vaccination.